(Total Views: 84)
Posted On: 03/29/2021 11:35:11 AM
Post# of 36260

$CURR CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline https://finance.yahoo.com/news/cure-pharmaceu...00116.html

